STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,927 | -59.7% | 15,210 | -14.8% | 0.00% | -100.0% |
| Q1 2023 | $148,699 | -32.1% | 17,851 | +174.8% | 0.00% | 0.0% |
| Q2 2021 | $219,000 | -47.4% | 6,495 | -39.4% | 0.00% | -50.0% |
| Q1 2021 | $416,000 | +14.6% | 10,712 | -1.2% | 0.00% | -60.0% |
| Q3 2020 | $363,000 | -36.8% | 10,837 | -46.6% | 0.01% | +66.7% |
| Q4 2019 | $574,000 | +23.2% | 20,286 | -6.5% | 0.00% | -25.0% |
| Q3 2019 | $466,000 | – | 21,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |